Triomics Raises $15M to Enhance Oncology Workflows with Generative AI.
Triomics specializes in processing free-text health record data at scale, improving patient-trial matching, quality of care operations, and delivering precision oncology.
Company Name: Triomics
Location: San Francisco, CA
Sector: Healthcare / AI
Funding Details: Raised $15M from Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator.
Purpose of Investment: To expand operations and development efforts.
Leadership: Led by Sarim Khan, CEO, and Hrituraj Singh, CTO.
Product: Develops oncology-specialized generative AI models (OncoLLMTM) and software to streamline workflows for cancer centers.
About Company: Triomics specializes in processing free-text health record data at scale, improving patient-trial matching, quality of care operations, and delivering precision oncology.
“Our investments in our core areas of focus have been deliberate. We have successfully merged expertise in two complex functional areas: our AI researchers, who are specialized in customizing language models to specific domains, and our clinical staff, who have decades of oncology-specific experience. As a result, our software can complement the strengths of these advanced models while also proactively addressing potential flaws, all with the intricacies of cancer research and care in mind.” - Hrituraj Singh